Delivery Order SPE2DB22D3301-SPE2DB26FX3WR
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for VENCLEXTA 100 mg tablets (120 count units) valued at $9,728.17, with an ultimate completion date of June 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The award represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VENCLEXTA 100 mg tablets (120-count units) valued at $9,728.17 under a firm fixed-price contract type. The award, issued on August 7, 2025, with an ultimate completion date of August 28, 2025, represents a non-competitive, competitively awarded delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $4,579.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for VENCLEXTA 100 mg tablets (28-count units) on July 30, 2025, with an ultimate completion date of August 20, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. Performance of this delivery order is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Venclexta 100 mg tablets (120-count units) valued at $9,728.17, with an ultimate completion date of October 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,456.34 to AmerisourceBergen Drug Corp for VENCLEXTA 100 MG tablets (120-count units) with a firm fixed price structure. This non-set-aside contract was competitively awarded on June 3, 2025, with an ultimate completion date of June 25, 2025. The award represents a child delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Venclexta 100 mg tablets (120 count) valued at $9,728.17. This competitively awarded, firm fixed-price delivery order is set to conclude by October 21, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency has awarded a delivery order valued at $4,648.16 to AmerisourceBergen Drug Corp for the supply of VENCLEXTA 50 mg tablets in unit dose packaging (7 tablets per package). This is a firm fixed-price contract with a completion date of October 20, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location....
- The Defense Logistics Agency awarded a $10,251.99 delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Venclexta 100 mg tablets (120-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 10, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with the DLA....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Venclexta 100 mg tablets (120-count units) with a contract ceiling value of $9,728.17. This is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Venclexta 100 mg tablets in quantities of 120 units. This firm fixed price delivery order, valued at $58,369.02, represents a non-competitive, non-set-aside award and is scheduled for completion by August 14, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB26FX3WRDelivery Order
The Defense Logistics Agency awarded a $19,456.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for VENCLEXTA 100 mg tablets (120-count units) on October 27, 2025, with completion targeted for November 18, 2025. This is a non-set-aside, competitively awarded contract with performance based in Conshohocken, Pennsylvania. The delivery order represents a child action under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement running through December 2026 that enables the company to supply comprehensive pharmaceutical products and medical supplies to support military healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across the Department of Defense healthcare ecosystem. The company's extensive portfolio under its DLA prime vendor agreement encompasses brand-name and generic medications, vaccines, specialty drugs, and medical devices across multiple therapeutic domains. This specific delivery order for VENCLEXTA, an oncology medication, exemplifies the company's role in supplying specialized pharmaceutical commodities to support military and veteran healthcare programs. AmerisourceBergen's consistent success in securing competitively awarded delivery orders across varying transaction values demonstrates its capability to meet federal medical supply requirements through the DLA Troop Support Medical prime vendor vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.5k | 10/27/25 |